Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06512584 |
| Consolidated Lead Sponsor | Chongqing Peg-Bio Biopharm Co |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 72 participants (ESTIMATED) |
| Registered Start Date | 2024-09-03 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Tsinghua Changgung Hospital | Beijing, China | Open Hospital Dossier -> |
| The Sixth Affiliated Hospital of Sun Yat-sen University | Guangzhou, China | Open Hospital Dossier -> |
| The Third Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
| The Affiliated Hospital of Qingdao University | Qingdao, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.